Shandong
688136.SSShandong Kexing Bioproducts Co,.Ltd Price (688136.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
198,219,089
(0.2424)%2023 - Income Statement Summary
| Revenue | 1.26B USD |
| Cost of Revenue | 370.31M USD |
| Gross Profit | 888.72M USD |
| Operating Expenses | 1.15B USD |
| Operating Income | -254201900.00 USD |
| Other Expenses | 175.06M USD |
| Net Income | -190290325.00 USD |
Income Statement
Shandong Kexing Bioproducts Co,.LtdCurrency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
615,840,135.00
+0% |
890,611,692.00
+45% |
1,190,766,325.00
+34% |
1,220,289,989.00
+2% |
1,285,171,728.00
+5% |
1,315,875,590.00
+2% |
1,259,035,600.00
-4% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 129,122,216.00 | 168,240,269.00 | 219,952,959.00 | 244,266,166.00 | 264,620,272.00 | 324,164,476.00 | 370,313,748.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
486,717,919.00
+0% |
722,371,423.00
+48% |
970,813,366.00
+34% |
976,023,823.00
+1% |
1,020,551,456.00
+5% |
991,711,114.00
-3% |
888,721,852.00
-10% |
||||||||||||
| Gross Profit Ratio | (0.79%) | (0.81%) | (0.82%) | (0.80%) | (0.79%) | (0.75%) | (0.71%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 32,347,415.00 | 42,676,846.00 | 46,169,652.00 | 60,110,738.00 | 122,950,814.00 | 193,296,701.00 | 344,796,850.00 | ||||||||||||
| General and Administrative | 9,352,251.00 | 54,078,013.00 | 22,718,235.00 | 20,050,550.00 | 29,897,235.00 | 28,437,565.00 | 7,692,799.00 | ||||||||||||
| Selling, General & Admin... | 337,007,122.00 | 522,157,797.00 | 669,941,553.00 | 675,590,198.00 | 785,498,009.00 | 856,171,808.00 | 627,655,559.00 | ||||||||||||
| Selling & Marketing Exp... | 327,654,871.00 | 468,079,784.00 | 647,223,317.00 | 655,539,647.00 | 755,600,773.00 | 827,734,242.00 | 619,962,760.00 | ||||||||||||
| Depreciation and Amortiz... | 8,204,000.00 | 9,387,200.00 | 12,891,600.00 | 33,691,514.00 | 56,625,630.00 | 81,013,620.00 | 88,259,156.00 | ||||||||||||
| Other Expenses | -14,697,519.11 | -1,687.61 | 44,805,219.00 | 56,537,704.00 | 66,349,541.00 | 62,048,194.00 | 175,062,864.00 | ||||||||||||
| Total Operating Expenses | 386,177,919.00 | 580,342,328.00 | 760,916,425.00 | 792,238,641.00 | 974,798,365.00 | 1,111,516,704.00 | 1,147,515,275.00 | ||||||||||||
| Cost and Exponses | 515,300,136.00 | 748,582,598.00 | 980,869,384.00 | 1,036,504,807.00 | 1,239,418,637.00 | 1,435,681,180.00 | 1,515,267,329.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
89,315,275.00
+0% |
121,270,238.00
+36% |
188,984,934.00
+56% |
159,849,644.00
-15% |
55,569,208.00
-65% |
-119,805,590.44
-316% |
-254,201,900.00
+112% |
||||||||||||
| Operating Income Ratio | (0.15%) | (0.14%) | (0.16%) | (0.13%) | (0.04%) | (-0.09%) | (-0.20%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 260,854.00 | 221,093.00 | 345,956.00 | 937,640.00 | 9,057,298.00 | 7,311,810.00 | 6,643,109.00 | ||||||||||||
| Interest Expenses | 6,692,332.00 | 11,157,232.00 | 6,665,214.00 | 10,327,300.00 | 8,025,874.00 | 26,306,619.00 | 41,121,815.00 | ||||||||||||
| Total Other Income/Exp... | -24,105,037.00 | -1,688.00 | -11,890,397.00 | -19,402,043.00 | 40,057,856.00 | -19,258,714.56 | -5,868,067.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 89,657,576.00 | 143,818,471.00 | 213,898,979.00 | 209,749,449.00 | 164,812,041.00 | -28,868,146.00 | -132,676,252.93 | ||||||||||||
| EBITDA ratio | (0.16%) | (0.18%) | (0.19%) | (0.17%) | (0.08%) | (-0.03%) | (-0.11%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 74,617,756.00 | 121,268,550.00 | 187,781,800.00 | 159,155,178.00 | 95,627,064.00 | -139,064,305.67 | -260,069,967.00 | ||||||||||||
| Income Before Tax Ratio | (0.12%) | (0.14%) | (0.16%) | (0.13%) | (0.07%) | (-0.11%) | (-0.21%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 15,226,106.00 | 27,104,864.00 | 27,971,444.00 | 20,018,010.00 | -836,849.70 | -46,240,444.47 | -64,583,444.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 59,391,649.00
+0% |
94,163,686.00
+59% |
159,810,355.00
+70% |
139,137,168.00
-13% |
96,463,914.00
-31% |
-92,823,861.20
-196% |
-190,290,325.00
+105% |
||||||||||||
| Net Income Ratio | (0.10%) | (0.11%) | (0.13%) | (0.11%) | (0.08%) | (-0.07%) | (-0.15%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.97 | 1.54 | 0.80 | 0.70 | 0.49 | -0.47 | -0.96 | ||||||||||||
| Diluted EPS | 0.97 | 1.54 | 0.80 | 0.70 | 0.49 | -0.47 | -0.96 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 61,228,505.00 | 61,145,251.00 | 198,700,650.00 | 198,700,650.00 | 198,700,650.00 | 198,700,650.00 | 198,219,089.00 | ||||||||||||
| Diluted Share Outstanding | 61,228,505.00 | 61,145,251.00 | 198,700,650.00 | 198,700,650.00 | 198,700,650.00 | 198,700,650.00 | 198,219,089.00 | ||||||||||||